210 related articles for article (PubMed ID: 10085004)
1. Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae.
Hammerschmidt S; Bethe G; Remane PH; Chhatwal GS
Infect Immun; 1999 Apr; 67(4):1683-7. PubMed ID: 10085004
[TBL] [Abstract][Full Text] [Related]
2. The effects of differences in pspA alleles and capsular types on the resistance of Streptococcus pneumoniae to killing by apolactoferrin.
Mirza S; Benjamin WH; Coan PA; Hwang SA; Winslett AK; Yother J; Hollingshead SK; Fujihashi K; Briles DE
Microb Pathog; 2016 Oct; 99():209-219. PubMed ID: 27569531
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of lactoferrin and lysozyme on Streptococcus pneumoniae killing.
André GO; Politano WR; Mirza S; Converso TR; Ferraz LF; Leite LC; Darrieux M
Microb Pathog; 2015 Dec; 89():7-17. PubMed ID: 26298002
[TBL] [Abstract][Full Text] [Related]
4. Characterization of binding of human lactoferrin to pneumococcal surface protein A.
Håkansson A; Roche H; Mirza S; McDaniel LS; Brooks-Walter A; Briles DE
Infect Immun; 2001 May; 69(5):3372-81. PubMed ID: 11292760
[TBL] [Abstract][Full Text] [Related]
5. Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae.
Ren B; Szalai AJ; Thomas O; Hollingshead SK; Briles DE
Infect Immun; 2003 Jan; 71(1):75-85. PubMed ID: 12496151
[TBL] [Abstract][Full Text] [Related]
6. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide.
Elass-Rochard E; Roseanu A; Legrand D; Trif M; Salmon V; Motas C; Montreuil J; Spik G
Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):839-45. PubMed ID: 8554529
[TBL] [Abstract][Full Text] [Related]
7. PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected].
Shaper M; Hollingshead SK; Benjamin WH; Briles DE
Infect Immun; 2004 Sep; 72(9):5031-40. PubMed ID: 15321996
[TBL] [Abstract][Full Text] [Related]
8. Identification of a human lactoferrin-binding protein in Staphylococcus aureus.
Naidu AS; Andersson M; Forsgren A
J Med Microbiol; 1992 Mar; 36(3):177-83. PubMed ID: 1548691
[TBL] [Abstract][Full Text] [Related]
9. Structure of a complex of human lactoferrin N-lobe with pneumococcal surface protein a provides insight into microbial defense mechanism.
Senkovich O; Cook WJ; Mirza S; Hollingshead SK; Protasevich II; Briles DE; Chattopadhyay D
J Mol Biol; 2007 Jul; 370(4):701-13. PubMed ID: 17543335
[TBL] [Abstract][Full Text] [Related]
10. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component.
Hammerschmidt S; Talay SR; Brandtzaeg P; Chhatwal GS
Mol Microbiol; 1997 Sep; 25(6):1113-24. PubMed ID: 9350867
[TBL] [Abstract][Full Text] [Related]
11. Unveiling molecular mechanisms of pneumococcal surface protein A interactions with antibodies and lactoferrin.
Jedrzejas MJ
Clin Chim Acta; 2006 May; 367(1-2):1-10. PubMed ID: 16513101
[TBL] [Abstract][Full Text] [Related]
12. The pavA gene of Streptococcus pneumoniae encodes a fibronectin-binding protein that is essential for virulence.
Holmes AR; McNab R; Millsap KW; Rohde M; Hammerschmidt S; Mawdsley JL; Jenkinson HF
Mol Microbiol; 2001 Sep; 41(6):1395-408. PubMed ID: 11580843
[TBL] [Abstract][Full Text] [Related]
13. Identification, characterization, and immunogenicity of the lactoferrin-binding protein from Helicobacter pylori.
Dhaenens L; Szczebara F; Husson MO
Infect Immun; 1997 Feb; 65(2):514-8. PubMed ID: 9009306
[TBL] [Abstract][Full Text] [Related]
14. Specific binding of lactoferrin to Escherichia coli isolated from human intestinal infections.
Naidu SS; Erdei J; Czirók E; Kalfas S; Gadó I; Thorén A; Forsgren A; Naidu AS
APMIS; 1991 Dec; 99(12):1142-50. PubMed ID: 1772651
[TBL] [Abstract][Full Text] [Related]
15. Bacterial lactoferrin-binding protein A binds to both domains of the human lactoferrin C-lobe.
Wong H; Schryvers AB
Microbiology (Reading); 2003 Jul; 149(Pt 7):1729-1737. PubMed ID: 12855724
[TBL] [Abstract][Full Text] [Related]
16. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS
Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
[TBL] [Abstract][Full Text] [Related]
17. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.
Singh R; Singh S; Sharma PK; Singh UP; Briles DE; Hollingshead SK; Lillard JW
PLoS One; 2010 Feb; 5(2):e9432. PubMed ID: 20195541
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae.
Crain MJ; Waltman WD; Turner JS; Yother J; Talkington DF; McDaniel LS; Gray BM; Briles DE
Infect Immun; 1990 Oct; 58(10):3293-9. PubMed ID: 1698178
[TBL] [Abstract][Full Text] [Related]
19. Surface Proteins and Pneumolysin of Encapsulated and Nonencapsulated Streptococcus pneumoniae Mediate Virulence in a Chinchilla Model of Otitis Media.
Keller LE; Bradshaw JL; Pipkins H; McDaniel LS
Front Cell Infect Microbiol; 2016; 6():55. PubMed ID: 27242973
[TBL] [Abstract][Full Text] [Related]
20. Human lactoferrin binding to Porphyromonas gingivalis, Prevotella intermedia and Prevotella melaninogenica.
Kalfas S; Andersson M; Edwardsson S; Forsgren A; Naidu AS
Oral Microbiol Immunol; 1991 Dec; 6(6):350-5. PubMed ID: 1726544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
